01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
Investment funds may face enhanced premerger reporting requirements under a new rule jointly propose...
Read More >
Seyfarth Synopsis: California’s Attorney General is drafting regulations that will shape employer o...
Read More >
You know that ERISA requires that the claimant receive “adequate notice in writing…setting forth t...
Read More >
You have undoubtedly read about the continuing popularity of special purpose acquisition companies (...
Read More >
The Securities and Exchange Commission (the “SEC”) recently adopted final rules (the “Final Rules...
Read More >
This two-part blog series discusses why buyers looking to make strategic purchases in the health car...
Read More >